Hering David 4
4 · Adagio Therapeutics, Inc. · Filed Sep 1, 2022
Insider Transaction Report
Form 4
Hering David
Chief Operating Officer
Transactions
- Purchase
Common Stock
2022-09-01$4.52/sh+8,000$36,160→ 8,000 total
Footnotes (1)
- [F1]The price in Column 4 is a weighted average purchase price. The prices actually paid ranged from $4.515 to $4.52. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range.